Published January 2021 | Version v1
Journal article

Dual-energy computed tomography image-based volumetric-modulated arc therapy planning for reducing the effect of contrast-enhanced agent on dose distributions

  • 1. Department of Radiation Oncology, Osaka International Cancer Institute, Osaka (Japan)
  • 2. Department of Medical Physics and Engineering, Osaka University Graduate School of Medicine, Suita (Japan)
  • 3. Department of Radiology, Kansai Medical University, Hirakata (Japan)

Description

To compare the effect of a contrast-enhanced (CE) agent on volumetric-modulated arc therapy plans based on four types of images—virtual monochromatic images (VMIs) captured at 70 and 140 keV (namely VMI70 and VMI140, respectively), water density image (WDI), and virtual non-contrast image (VNC) generated using a dual-energy computed tomography (DECT) system. A tissue characterization phantom and a multi-energy phantom were scanned, and VMI70, VMI140, WDI, and VNC were retrospectively reconstructed. For each image, a lookup table (LUT) was created. For 13 patients with nasopharyngeal cancer, non-CE and CE scans were performed, and volumetric-modulated arc therapy plans were generated on the basis of non-CE VMI70. Subsequently, the doses were re-calculated using the four types of DECT images and their corresponding LUTs. The maximum differences in the physical density estimation were 21.3, 5.2, −3.9, and 0.5% for VMI70, VMI140, WDI, and VNC, respectively. Compared with VMI70, the WDI approach significantly reduced (p < 0.05) the dosimetric difference due to the CE agent for the planning target volume (PTV) (D50%), whereas the difference was significantly increased for D1%. Except for PTV (D1%), the differences were significantly lower (p < 0.05) in the treatment plans based on VMI140 and VNC than that based on VMI70. For the VNC, the mean difference was less than 0.2% for all dosimetric parameters for the PTV. For patients with NPC, treatment plans based on the VNC derived from CE scan showed the best agreement with those based on the non-CE VMI70. Ideally, the effect of CE agent on dose distribution does not appear in treatment planning procedures.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.meddos.2021.03.006

Additional details

Identifiers

DOI
10.1016/j.meddos.2021.03.006;
PII
S0958394721000261;

Publishing Information

Journal Title
Medical Dosimetry
Journal Volume
46
Journal Issue
4
Journal Page Range
p. 328-334
ISSN
0958-3947

Optional Information

Copyright
Copyright (c) 2021 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.